VTGN logo

VTGN
VistaGen Therapeutics Inc

18,134
Mkt Cap
$22.2M
Volume
290,258.00
52W High
$5.14
52W Low
$0.43
PE Ratio
-0.35
VTGN Fundamentals
Price
$0.5604
Prev Close
$0.5559
Open
$0.559
50D MA
$0.5788
Beta
1.93
Avg. Volume
470,068.26
EPS (Annual)
-$1.67
P/B
0.44
Rev/Employee
$8,526.32
$1.78
Loading...
Loading...
News
all
press releases
CLASS ACTION DEADLINE TONIGHT MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline Tonight
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vistagen Therapeutics, Inc. (Vistagen or the Company) (NASDAQ: VTGN) and reminds investors of...
Business Wire·27d ago
News Placeholder
More News
News Placeholder
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities...
PR Newswire·27d ago
News Placeholder
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc...
PR Newswire·27d ago
News Placeholder
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·27d ago
News Placeholder
VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP...
PR Newswire·1mo ago
News Placeholder
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact Levi & Korsinsky
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact Levi & Korsinsky Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16...
PR Newswire·1mo ago
News Placeholder
LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS ACTION AGAINST VISTAGEN THERAPEUTICS MAY IMPACT PORTFOLIO HOLDINGS
LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS ACTION AGAINST VISTAGEN THERAPEUTICS MAY IMPACT PORTFOLIO HOLDINGS LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS...
PR Newswire·1mo ago
News Placeholder
Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN)
Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN) Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against...
PR Newswire·1mo ago
News Placeholder
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities...
PR Newswire·1mo ago
News Placeholder
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·1mo ago
<
1
2
...
>

Latest VTGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.